Navigation Links
Reportlinker Adds Pediatric Health Care Products and Services Report
Date:9/3/2009

EAR INFECTIONS

UPPER RESPIRATORY INFECTIONS

MARKET FORECASTS FOR CHRONIC ILLNESSES

ALLERGIES

ATTENTION DEFICIT DISORDERS

ASTHMA

AUTISM SPECTRUM DISORDERS

DIABETES

OBESITY

CHAPTER THREE: OVERVIEW OF THE PEDIATRIC HEALTHCARE INDUSTRY

TABLE 1 PROJECTED PEDIATRIC PREVENTATIVE CARE COSTS FROM BIRTH THROUGH AGE 18 IN THE U.S., THROUGH 2013 ($ MILLIONS)

PRENATAL CARE/IMPLICATIONS

INTERNATIONAL PRENATAL CARE/IMPLICATIONS

Low Birth Weight

NEWBORN CARE

CARE IN THE U.S.

INTERNATIONAL NEWBORN CARE

Malnutrition

CHILDREN AGE 1 TO 6

CHILDREN AGE 7 TO 12

ADOLESCENT CHILDREN AGE 13 TO 18

ADOLESCENT REPRODUCTIVE HEALTH

SEXUALLY TRANSMITTED DISEASES

Human papillomavirus (HPV)

VACCINES/IMMUNIZATIONS

TABLE 2 IMMUNIZATION SCHEDULE FOR CHILDREN FROM BIRTH TO 6 MONTHS

TABLE 3 IMMUNIZATION SCHEDULE FOR CHILDREN FROM 12 MONTHS TO 4 TO 6 YEARS

TABLE 4 IMMUNIZATION SCHEDULE FOR CHILDREN AND ADOLESCENTS FROM 7 TO 18

VACCINE EFFICACY AND CONTROVERSY

IMPLICATIONS FOR FUTURE DEVELOPMENTS IN THE U.S.

CHAPTER FOUR: SHORT-TERM ILLNESSES IN THE PEDIATRIC POPULATION

TABLE 5 GLOBAL COSTS OF THREE PRIMARY SHORT-TERM ILLNESSES IN PEDIATRIC POPULATION, THROUGH 2013 ($ MILLIONS)

FIGURE 1 GLOBAL COST OF PEDIATRIC SHORT-TERM ILLNESS, 2008 AND 2013 ($ MILLIONS)

OTITIS MEDIA (EAR INFECTIONS)

CAUSES OF OTITIS MEDIA

Allergies

Infection

Blockage

Nutrition and breastfeeding

TYPES AND SYMPTOMS

TREATMENT

Pharmacological intervention

Use of Prevnar

TABLE 6 GLOBAL PRESCRIPTION COSTS FOR TREATMENT OF PEDIATRIC OTITIS MEDIA, TH
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Reportlinker Adds Biologic Imaging Reagents: Technologies and Global Markets Report
2. Reportlinker Adds Dermatological Therapeutics: Global Markets Report
3. Reportlinker Adds Markets for Advanced Wound Care Technologies Report
4. Reportlinker Adds Antiseptics and Disinfectants Report
5. Reportlinker Adds Commercial Amino Acids Report
6. Reportlinker Adds Membrane & Separation Technology News Review, 2008 Report
7. Reportlinker Adds the Dental Market: Techniques, Equipment and Materials Report
8. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
9. Parental surveys boost diagnosis abilities of pediatricians
10. Nautica Malibu Triathlon Presented by Toyota Raises $718,000 for Childrens Hospital Los Angeles Pediatric Cancer Research
11. Super Jake Foundation Offers Hope for Pediatric Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/3/2015)... (PRWEB) , ... August 03, 2015 , ... ... technologies and development solutions for drugs, biologics and consumer health products, today welcomed ... accepted for review OPKO’s New Drug Application for a new treatment for chronic ...
(Date:8/3/2015)... ... 03, 2015 , ... The art of preparing and cooking food comes naturally ... a young age, Nasreen Zereshki was extremely eager to cook Persian cuisine. Now that ... from My Persian Kitchen with the world. , Since Americans tend to be undereducated ...
(Date:8/3/2015)... ... August 03, 2015 , ... The U.S. Food and Drug Administration ... is similar to deoxycholic acid, which occurs naturally in the body and helps absorb ... treat this area of the body. These are invasive procedures and very expensive for ...
(Date:8/3/2015)... ... ... Dignity Health named Dr. Norris A. Baldwin, Jr. the Facility Medical Director of ... The new facility is licensed under Dignity Health Arizona General Hospital , ... an excellent leader and will ensure our new freestanding emergency room delivers the highest ...
(Date:8/3/2015)... ... August 03, 2015 , ... ... provider of medical information, risk management and investigative services, has introduced a ... toward focused, expert information solutions that improve business outcomes for its customers. ...
Breaking Medicine News(10 mins):Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 2Health News:Catalent’s OptiShell™ Technology is Delivery Platform for OPKO Health’s New Chronic Kidney Disease Treatment 3Health News:Persian Cuisine: Colorful and Extremely Healthy 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 2Health News:Dr. Ava Shamban to Offer the New Double Chin Treatment Kybella 3Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 2Health News:Dignity Health Names Dr. Norris A. Baldwin, Jr. Facility Medical Director of New Freestanding Emergency Room 3Health News:EMSI Announces New Branding: Powerful Information. Improved Outcomes. 2
... Vietnam is badly hit by a rubella epidemic, with more ... seem to be worst affected//, said a Government health official. ... year has reached 6,000,’ said Pham Ngoc Dinh, deputy director ... ,One of the largest outbreaks has been in Ho Chi ...
... Rush University have developed ,the first knee replacement shaped ... from the U.S. Food and Drug Administration, and will ... // ,Dr. Aaron G. Rosenberg and Dr. Richard A. ... surgeons who sought to address shape-related differences of a ...
... research in the promising field of nanotechnology, scientists have ... test tubes//. These findings have the potential to revolutionize ... filled with anti-cancer drugs and injected into cancer patients, ... the tiniest tubes, scientists have made, are about 80 ...
... for providing information on dozens of diseases. The Best ... and jargon-free information. // ,Concerned about number ... leaving the GPs overwhelmed with visits from “cyberchondriacs” has ... ,It has sections on men's, women's and children's health ...
... content of beverages such as tea, coffee and soda may ... the decaf label that claims reduced or nil caffeine content. ... School of Medicine, is based on a dipstick analysis. The ... journal, Analytical Chemistry, a publication of the American Chemical Society. ...
... nurses along with a Palestinian doctor were accused of infecting ... 426 children with AIDS contaminated blood at a local hospital. ... But on Christmas their penalty were quashed. Till now fifty-one ... appealed and the court ordered a retrial, and scrapped the ...
Cached Medicine News:Health News:Shapelier Knee Replacements for Women 2Health News:Shapelier Knee Replacements for Women 3Health News:Shapelier Knee Replacements for Women 4Health News:Tiniest Nanoscale Test Tubes Corked; Holds Promise In Cancer Treatment 2Health News:Caffeine Content In Beverages To Be Identified By Home Test Kit 2
(Date:8/3/2015)... , August 3, 2015 ... announced today that it has acquired ... Inc. for $300 million. With the acquisition, Shire ... drops combining 0.6% povidone iodine (PVP-I) and 0.1% ... treatment of infectious conjunctivitis, an ocular surface condition ...
(Date:8/2/2015)... 2015  Isis Pharmaceuticals, Inc. (NASDAQ: ISIS ... to discover and develop antisense therapies for cardiovascular, ... on a broad existing relationship between the two ... therapeutic areas using novel RNA-targeted treatments. It also ... antisense technology to diseases of the kidney. ...
(Date:8/2/2015)... Texas , Aug. 3, 2015  Lexicon ... that the pivotal TELESTAR Phase 3 clinical trial ... oral telotristat etiprate in treating cancer patients with ... the current standard of care. Telotristat etiprate was ... Prize-winning technology, and is the company,s first discovery ...
Breaking Medicine Technology:Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 2Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 3Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 4Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 5Shire Acquires Privately Held Foresight Biotherapeutics Inc., Boosting Ophthalmics Portfolio with Late-Stage Asset 6AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 2AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 3AstraZeneca and Isis Pharmaceuticals to Discover and Develop Antisense Drugs for Cardiovascular, Metabolic and Renal Diseases 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 2Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 3Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 4Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 5Lexicon Pharmaceuticals Reports Positive Top-Line Results For Pivotal Phase 3 Telotristat Etiprate Study In Cancer Patients With Carcinoid Syndrome 6
... 7, 2010 Where do you start when trying to ... ), an independent nonprofit that researches the best approaches to ... release of its 5th annual list of Top 10 ... free download with registration, the list features the ...
... Research Group (MRG), the global authority on medical technology ... the US clot management device market.   ... report provides important insight into the device-based treatments ... of medical device manufacturers in this field. The report ...
Cached Medicine Technology:ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 2ECRI Institute Releases 'Top 10 Health Technology Hazards for 2011' 3Millennium Research Group to Release Their Latest US Clot Management Data 2
Invacare 5 Oxygen Concentrator with Sens O2, 230 VAC - Intl....
... Nine out of ten peptic ulcers ... can deliver improved patient care while the ... that fits the staffing requirements of waived ... Facilities: the most sensitive CLIA-waived rapid H. ...
... the Japanese market:, ,QuietLife 3 ... low-power-consumption, high-performance oxygen concentrator for home ... in an attractive, lightweight (26 kg) ... to meet the requirements of the ...
... Oxygen Concentrator is a low decibel, low ... oxygen for prescriptions up to 5 liters ... running concentrator at <40 dBA, this unit ... Concentrators are also an economical and safe ...
Medicine Products: